Transcode Therapeutics Inc (RNAZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $22.35M
Last updated: Nov 17, 2026 at 11:02 AM ET
Transcode Therapeutics Inc (RNAZ) Competitors
The companies most similar to Transcode Therapeutics are Plus Therapeutics (PSTV), Context Therapeutics (CNTX) and Telomir Pharmaceuticals, Inc. Common Stock (TELO). By market cap, Transcode Therapeutics ranks 7th of the 13 companies on this page; Grace Therapeutics (GRCE) is the largest at $38.08M.
Peer Comparison
RNAZ's ROIC of -412.7% is below the peer median of -129.7%, and its revenue growth of 0.0% is above the median of -1.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Transcode Therapeutics (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD) | $15.74M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Marker Therapeutics Inc (MRKR) | $14.51M | N/A | 14.5x | -245.5% | N/A | -51.0% | 0.00% |
| Tscan Therapeutics Inc (TCRX) | $10.89M | N/A | 3.6x | 0.0% | -129.7% | -65.8% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Cocrystal Pharma Inc (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Peer median | $22.22M | N/A | 3.6x | 0.0% | -129.7% | -1.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Transcode Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Tvardi Therapeutics, Inc. (TVRD) | Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet... | TVRD competitors |
| Marker Therapeutics Inc (MRKR) | Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based... | MRKR competitors |
| Tscan Therapeutics Inc (TCRX) | Tscan Therapeutics Inc (TCRX) is a pioneering clinical-stage biotechnology company specializing in precision oncology through its proprietary T cell receptor... | TCRX competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Cocrystal Pharma Inc (COCP) | Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic... | COCP competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
Frequently Asked Questions About RNAZ
Who are Transcode Therapeutics' main competitors?
The companies most similar to Transcode Therapeutics include Plus Therapeutics (PSTV), Context Therapeutics (CNTX), Telomir Pharmaceuticals, Inc. Common Stock (TELO), Tvardi Therapeutics (TVRD) and Marker Therapeutics (MRKR), listed from the closest match.
Who is Transcode Therapeutics' biggest competitor?
Grace Therapeutics (GRCE) is the largest of the similar companies at $38.08M; Plus Therapeutics (PSTV) is the closest match by business profile, size, sector and industry.
How does RNAZ stock compare with its competitors?
RNAZ's net margin is 0.0% against a peer median of 0.0%.
Which of Transcode Therapeutics' competitors pays a higher dividend?
Transcode Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Transcode Therapeutics bigger than its competitors?
No. Transcode Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Grace Therapeutics (GRCE) at $38.08M.
RNAZ pages: Overview, Earnings, Financials, Competitors